侵袭性甲状腺癌 临床和分子特征:系统性审查
Sorina Schipor1, Mihai Alin Publik2, Dana Manda1
1Department of Research, "C.I. Parhon" National Institute of Endocrinology, 011863 Bucharest, Romania.
International journal of molecular sciences
|June 26, 2025
概括
这种对侵袭性甲状腺癌的系统审查显示,差异化高度甲状腺癌的预后最好,其次是差异化,然后是形甲状腺癌,突出了不同的临床和分子形状.
科学领域:
- 内分泌学和瘤学 在内分泌学和瘤学.
- 甲状腺癌研究研究
- 分子病理学分子病理学
背景情况:
- 侵袭性甲状腺癌,包括差异化高度 (DHGTC),差异化差异化 (PDTC) 和厌塑性甲状腺癌 (ATC),是罕见但具有破坏性的恶性瘤,对其结果的文献有限.
- 关于临床结果,预后因素和突变特征的现有数据往往不同,需要进行全面的审查.
结论:
- 侵袭性甲状腺癌的预后遵循一个明确的梯度:DHGTC > PDTC > ATC.
- 了解这些侵袭性甲状腺癌的独特临床和分子特征对于有针对性的治疗策略和改善患者治疗结果至关重要.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
5.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.2K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


